Q I have a patient, a 9-year-old boy, whose family recently moved to a new neighborhood. Every morning since the boy started attending his new school, he has complained of nausea and had at least one episode of emesis, either before leaving for school or on the way there.
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.